Physician profile
Gulle Awan
NPI 1538302179
$1,783.40
in general payments reported to CMS, 2019-2025
22 companies · $195 in 2025
The $195 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $207 · 2020: $225 · 2021: $157 · 2022: $446 · 2023: $316 · 2024: $238 · 2025: $195.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $749.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $748.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $628.58 | 2022-2025 | Botox, Ubrelvy |
| Boston Scientific Corporation | $162.99 | 2023-2025 | Intracept, General - Pain Management |
| Nevro Corp. | $140.52 | 2020-2024 | Senza |
| Horizon Therapeutics Plc | $97.64 | 2019-2022 | |
| Allergan, INC. | $96.77 | 2020-2022 | |
| Si-Bone, INC. | $94.48 | 2019-2022 | |
| Daiichi Sankyo INC. | $75.08 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $56.16 | 2024 | |
| Lilly USA, LLC | $53.50 | 2019 | |
| Stimwave Technologies Incorporated | $50.00 | 2020 | |
| Curonix LLC | $49.26 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Collegium Pharmaceutical, INC. | $36.80 | 2020 | |
| Neuronetics, INC. | $35.60 | 2019 | |
| Globus Medical, INC. | $31.46 | 2025 | Senza |
| Biodelivery Sciences International, INC. | $31.20 | 2019-2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Painteq LLC | $30.78 | 2021 | |
| Medtronic, INC. | $21.73 | 2021 | |
| Scilex Pharmaceuticals INC. | $21.42 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.07 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $17.93 | 2023 | Seglentis |
| G Medical Diagnostic Services, INC. | $17.18 | 2021 | |
| Forte Bio-Pharma LLC | $16.25 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gulle Awan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.